Class information for:
Level 1: INHIBITORS OF ANGIOTENSINOGEN CONVERTING ENZYME//ACE ID//AGTR1 GENE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
17384 602 42.7 88%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
8 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1276458
57 3       ANGIOTENSIN II//HYPERTENSION//PERIPHERAL VASCULAR DISEASES 89232
85 2             ANGIOTENSIN II//RENIN ANGIOTENSIN SYSTEM//ANGIOTENSIN 27105
17384 1                   INHIBITORS OF ANGIOTENSINOGEN CONVERTING ENZYME//ACE ID//AGTR1 GENE 602

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 INHIBITORS OF ANGIOTENSINOGEN CONVERTING ENZYME authKW 101444 0% 100% 2
2 ACE ID authKW 67628 0% 67% 2
3 AGTR1 GENE authKW 67628 0% 67% 2
4 INVERSE PROBABILITY OF TREATMENT WEIGHT authKW 67628 0% 67% 2
5 ANGIOTENSIN II authKW 67316 17% 1% 102
6 INSERMU541 address 65211 0% 43% 3
7 RENIN ANGIOTENSIN SYSTEM authKW 56761 11% 2% 65
8 ANGIOTENSIN II TYPE 1 RECEPTOR authKW 53848 3% 6% 18
9 1CAD WARD address 50722 0% 100% 1
10 A 1 7 authKW 50722 0% 100% 1

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 2653 35% 0% 211
2 Peripheral Vascular Diseases 827 11% 0% 69
3 Medicine, Research & Experimental 320 10% 0% 58
4 Urology & Nephrology 197 6% 0% 36
5 Endocrinology & Metabolism 91 6% 0% 36
6 Cardiac & Cardiovascular System 80 6% 0% 35
7 Gastroenterology & Hepatology 74 4% 0% 25
8 Cell Biology 63 7% 0% 44
9 Dermatology 55 3% 0% 17
10 Pharmacology & Pharmacy 43 8% 0% 46

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 INSERMU541 65211 0% 43% 3
2 1CAD WARD 50722 0% 100% 1
3 A SURG CLIN 50722 0% 100% 1
4 AFFILIATED SUZHOU HOSP TCM 50722 0% 100% 1
5 ANIM WELF INTEGR 50722 0% 100% 1
6 AREA FISIOL HLTH SCI 50722 0% 100% 1
7 BIOMED SCI POST UATE TRAINING 50722 0% 100% 1
8 BIOSIT CIC0203 50722 0% 100% 1
9 BIOSIT UMR6290 50722 0% 100% 1
10 BIOTECHNOL NAT POLYMER BIOPOL 50722 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM 30515 4% 3% 23
2 CURRENT CANCER DRUG TARGETS 2602 1% 1% 7
3 PROSTATE 2491 2% 0% 15
4 ONCOLOGY REPORTS 718 2% 0% 12
5 TUMOR BIOLOGY 654 1% 0% 9
6 WOUND REPAIR AND REGENERATION 542 1% 0% 4
7 BRITISH JOURNAL OF CANCER 533 2% 0% 14
8 ENDOCRINE-RELATED CANCER 484 1% 0% 4
9 CURRENT HYPERTENSION REPORTS 432 0% 0% 3
10 WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE 419 0% 0% 3

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 INHIBITORS OF ANGIOTENSINOGEN CONVERTING ENZYME 101444 0% 100% 2 Search INHIBITORS+OF+ANGIOTENSINOGEN+CONVERTING+ENZYME Search INHIBITORS+OF+ANGIOTENSINOGEN+CONVERTING+ENZYME
2 ACE ID 67628 0% 67% 2 Search ACE+ID Search ACE+ID
3 AGTR1 GENE 67628 0% 67% 2 Search AGTR1+GENE Search AGTR1+GENE
4 INVERSE PROBABILITY OF TREATMENT WEIGHT 67628 0% 67% 2 Search INVERSE+PROBABILITY+OF+TREATMENT+WEIGHT Search INVERSE+PROBABILITY+OF+TREATMENT+WEIGHT
5 ANGIOTENSIN II 67316 17% 1% 102 Search ANGIOTENSIN+II Search ANGIOTENSIN+II
6 RENIN ANGIOTENSIN SYSTEM 56761 11% 2% 65 Search RENIN+ANGIOTENSIN+SYSTEM Search RENIN+ANGIOTENSIN+SYSTEM
7 ANGIOTENSIN II TYPE 1 RECEPTOR 53848 3% 6% 18 Search ANGIOTENSIN+II+TYPE+1+RECEPTOR Search ANGIOTENSIN+II+TYPE+1+RECEPTOR
8 A 1 7 50722 0% 100% 1 Search A+1+7 Search A+1+7
9 AGT1R GENE 50722 0% 100% 1 Search AGT1R+GENE Search AGT1R+GENE
10 AGTR1 A1166T 50722 0% 100% 1 Search AGTR1+A1166T Search AGTR1+A1166T

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 ROSENTHAL, T , GAVRAS, I , (2009) ANGIOTENSIN INHIBITION AND MALIGNANCIES: A REVIEW.JOURNAL OF HUMAN HYPERTENSION. VOL. 23. ISSUE 10. P. 623 -635 60 83% 33
2 GEORGE, AJ , THOMAS, WG , HANNAN, RD , (2010) THE RENIN-ANGIOTENSIN SYSTEM AND CANCER: OLD DOG, NEW TRICKS.NATURE REVIEWS CANCER. VOL. 10. ISSUE 11. P. 745-759 83 44% 117
3 DOLLEY-HITZE, T , VERHOEST, G , JOUAN, F , LE POGAMP, P , ARLOT-BONNEMAINS, Y , OGER, E , BELAUD-ROTUREAU, MA , RIOUX-LECLERCQ, N , VIGNEAU, C , (2013) ANGIOTENSIN-2 TYPE 1 RECEPTORS (AT1R) AND CANCERS.NEPHROLOGIE & THERAPEUTIQUE. VOL. 9. ISSUE 2. P. 85-91 52 78% 2
4 ANDRAS, T , ISTVAN, K , (2015) ONCOLOGY-RELATED ISSUES OF ANGIOTENSIN-RECEPTOR BLOCKERS.ORVOSI HETILAP. VOL. 156. ISSUE 11. P. 423 -430 42 84% 0
5 MIYAJIMA, A , KOSAKA, T , KIKUCHI, E , OYA, M , (2015) RENIN-ANGIOTENSIN SYSTEM BLOCKADE: ITS CONTRIBUTION AND CONTROVERSY.INTERNATIONAL JOURNAL OF UROLOGY. VOL. 22. ISSUE 8. P. 721 -730 58 55% 4
6 VERHOEST, G , DOLLEY-HITZE, T , JOUAN, F , BENSALAH, K , ARLOT-BONNEMAINS, Y , DUGAY, F , BELAUD-ROTUREAU, MA , RIOUX-LECLERCQ, N , VIGNEAU, C , (2014) RENIN-ANGIOTENSIN SYSTEM AND UROLOGICAL CANCERS.PROGRES EN UROLOGIE. VOL. 24. ISSUE 2. P. 73-79 42 78% 4
7 RUITER, R , VISSER, LE , VAN DUIJN, CM , STRICKER, BHC , (2011) THE ACE INSERTION/DELETION POLYMORPHISM AND RISK OF CANCER, A REVIEW AND META-ANALYSIS OF THE LITERATURE.CURRENT CANCER DRUG TARGETS. VOL. 11. ISSUE 4. P. 421-430 43 72% 10
8 REGULSKA, K , STANISZ, B , REGULSKI, M , (2013) THE RENIN-ANGIOTENSIN SYSTEM AS A TARGET OF NOVEL ANTICANCER THERAPY.CURRENT PHARMACEUTICAL DESIGN. VOL. 19. ISSUE 40. P. 7103 -7125 82 36% 1
9 XIE, YB , YOU, C , CHEN, J , (2014) AN UPDATED META-ANALYSIS ON ASSOCIATION BETWEEN ANGIOTENSIN I-CONVERTING ENZYME GENE INSERTION/DELETION POLYMORPHISM AND CANCER RISK.TUMOR BIOLOGY. VOL. 35. ISSUE 7. P. 6567 -6579 34 71% 2
10 WEGMAN-OSTROSKY, T , SOTO-REYES, E , VIDAL-MILLAN, S , SANCHEZ-CORONA, J , (2015) THE RENIN-ANGIOTENSIN SYSTEM MEETS THE HALLMARKS OF CANCER.JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. VOL. 16. ISSUE 2. P. 227 -233 28 68% 9

Classes with closest relation at Level 1


Rank Class id link
1 30346 AT1A MRNA//ABCB4 KNOCKOUT//ANGIOTENSIN ANG 1 7
2 29713 OCULAR RENIN ANGIOTENSIN SYSTEM//REN 2 RAT//S PHARMACOL MOL BIOL
3 21605 POSTINFARCTION ARRHYTHMIAS//SPRINT STUDY GRP//CALCIUM CHANNEL BLOCKERS
4 2699 AT2 RECEPTOR//ANGIOTENSIN II RECEPTOR//ANGIOTENSIN RECEPTORS
5 29762 GONDA GOLD MIED VASC SURG//ATHEROSCLERSSIS//BARE METAL STENT IMPLANTATION
6 22028 ACSDKP//N ACETYL SERYL ASPARTYL LYSYL PROLINE//HEMOREGULATORY PEPTIDE
7 30542 ESCOLA PROF LUIZ C ELO//ANGIOTENSIN II TYPE IA RECEPTOR//ANGIOTENSIN II TYPE IA RECEPTOR ANTAGONIST
8 6313 ANGIOTENSIN 1 7//ANGIOTENSIN CONVERTING ENZYME 2//MAS RECEPTOR
9 17317 NORMAN COUSINS//COUSINS PNI//NEONEUROGENESIS
10 11979 TELMISARTAN//AZILSARTAN//AZILSARTAN MEDOXOMIL

Go to start page